Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Pre-Stabilisation Notice - BBVA

17 Mar 2021 07:00

RNS Number : 4795S
UBS AG
16 March 2021
 

16/03/2021

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

 

Pre-Stabilisation Notice

UBS Investment Bank (contact: Debt Syndicate; telephone: +44 20 7567 2477) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

The securities:

Issuer:

Banco Bilbao Vizcaya Argentaria SA

Guarantor (if any): 

N/A

Aggregate nominal amount:

EUR1bn

Description:

BBVA EUR 6nc5

Offer price:

[TBC]

Other offer terms:

[TBC]

Stabilisation:

Stabilising Manager(s):

UBS AG together with the lead managers:

BBVA, BNP Paribas, Mediobanca, Natixis, Unicredit 

Stabilisation period expected to start on:

16/03/2021

Stabilisation period expected to end no later than:

21/04/2021

Maximum size of over-allotment facility:

[Up to 5% of the aggregate nominal amount stated above]

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States. END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFZGMFRVKGMZM
Date   Source Headline
1st Jun 202610:20 amRNSPeriodic Report on the Buyback Program 01/06/2026
26th May 20267:00 amRNSPeriodic Report on the Buyback Program 25/05/2026
18th May 202610:18 amRNSPeriodic Report on the Buyback Program 18/05/2026
12th May 20266:23 pmRNSHR - Fitch rating upgrade
11th May 202610:17 amRNSPeriodic Report on the Buyback Program 11/05/2026
1st May 20267:00 amRNSIssue of preferred sec. contingently convertible
1st May 20267:00 amRNSChanges in BBVA’s Board of Directors
30th Apr 20268:39 amRNSShare Buyback Program
30th Apr 20267:19 amRNS1Q26 Earnings Presentation
30th Apr 20267:16 amRNS1Q26 Quarterly Report
30th Apr 20267:12 amRNSResults Press Release BBVA 1T2026
22nd Apr 20261:24 pmRNS1T26 Earnings Presentation Announcement
20th Apr 20267:00 amRNSCompletion of the execution of the Second Tranche
17th Apr 20267:14 amRNSEarly redemption of public sector covered bonds
15th Apr 20262:57 pmRNSBBVA Notice to amend final terms GMTN 29
14th Apr 20265:20 pmRNSMREL requirement
13th Apr 202610:19 amRNSPeriodic Report on the Buyback Program 13/04/2026
7th Apr 20267:00 amRNSPeriodic Report on the Buyback Program 06/04/2026
31st Mar 20265:50 pmRNSBBVAs share capital reduction
23rd Mar 20267:00 amRNSPilar 3 Report 2025
20th Mar 202611:50 amRNSShare Buyback Program
6th Mar 20266:19 pmRNSCompletion of the execution of the First Tranche
2nd Mar 202610:18 amRNSPeriodic Report on the Buyback Program 2026/03/02
23rd Feb 202610:29 amRNSPeriodic Report on the Buyback Program 23/02/2026
19th Feb 202610:46 amRNS2025_Individual_Annual_Accounts_and_Management_Rep
19th Feb 202610:37 amRNS2025_Cons_Annual_Accounts_and_Management_Report
16th Feb 202610:24 amRNSPeriodic Report on the Buyback Program 2026/02/16
13th Feb 20265:22 pmRNSApril dividend calendar
13th Feb 20263:33 pmRNS2026 AGM Notice and Proposed Resolutions
11th Feb 20265:44 pmRNSEarly redemption of Senior Preferred Notes
10th Feb 20267:00 amRNS2026 Annual General Meeting Call
9th Feb 202610:11 amRNSPeriodic Report on the Buyback Program 2026/02/09
5th Feb 20267:00 amRNSShareholder remuneration for 2025
5th Feb 20267:00 amRNS4Q25 Earnings Report
5th Feb 20267:00 amRNS4Q25 Earnings Press Release
5th Feb 20267:00 amRNS4Q25 Earnings Presentation
2nd Feb 202610:27 amRNSPeriodic Report on the Buyback Program 02/02/2026
28th Jan 20261:29 pmRNS4Q25 Earnings Presentation Announcement
27th Jan 20267:00 amRNSNew Periodic Report Buyback Program 26/01/2026
26th Jan 202610:30 amRNSPeriodic Report on the Buyback Program 26/01/2026
19th Jan 202610:06 amRNSPeriodic Report on the Buyback Program 19/01/2026
12th Jan 202610:18 amRNSPeriodic Report on the Buyback Program 12/01/2026
2nd Jan 202610:39 amRNSPeriodic Report on the Buyback Program 02/01/2026
23rd Dec 20255:28 pmRNSBBVA's share capital reduction
23rd Dec 20255:28 pmRNSBBVA's share capital reduction
19th Dec 20257:21 amRNSShare Buyback Program
19th Dec 20257:21 amRNSShare Buyback Program
17th Dec 20257:47 amRNSEarly redemption of the entire issuance
11th Dec 20257:00 amRNSCompletion of the execution of the Buyback Program
9th Dec 202510:30 amRNSPeriodic Report on the Buyback Program 2025/12/09

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.